Quanta, Inc.

Quanta, Inc.

QNTA
Quanta, Inc.US flagOther OTC
0.00
USD
- -
- -
40,659.00Market Cap
Quanta, Inc.
QNTA
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Quanta, Inc. (Nasdaq: QNTA) operates as an e-commerce platform specializing in consumer health and wellness products. The company offers a wide range of supplements, vitamins, and nutritional aids through its BuyQuanta.com website, including branded categories such as immune support, joint health, digestive wellness, and performance enhancers; it also provides subscription-based delivery services, personalized recommendation tools, and bundled product kits tailored for fitness enthusiasts, seniors, and families. Quanta serves retail customers primarily in North America, with expanding operations into Europe and Asia via international shipping partnerships. Founded in 2018 and headquartered in Austin, Texas, the company focuses on direct-to-consumer sales in the health supplements industry, targeting health-conscious individuals and wellness retailers. In late 2024, Quanta announced a strategic rebranding initiative to unify its product lines under a streamlined brand identity, alongside a major funding round exceeding $50 million to fuel expansion into AI-driven personalization services and new product launches in sustainable, plant-based nutraceuticals. This follows its 2023 acquisition of a complementary vitamin formulation subsidiary, enhancing its manufacturing capabilities and supply chain resilience.

Company News

  • QNTA Secures Additional Enterprise Software Automation Contracts

  • Quanta AI Completes Name Change

  • Can Quanta Overcome Macro Headwinds With Record Project Demand?

  • Quanta Services: A Strong Backlog And An Even Bigger Opportunity

  • Quanta's 65% YTD Surge: Can Infrastructure Demand Fuel More Gains?

  • Quanta Services Announces Third Quarter 2026 Earnings Release & Webcast Schedule

  • Quanta: At The Second Inning Of A Multi-Year Cycle

  • Quanta Sees 220%-240% Load Center Growth: Can the Boom Last?

  • Quanta Services: Big Bet On AI Infrastructure And Data Centers

  • Why Quanta Services Stock Flew Higher on Friday

  • Quanta Targets Up to $2.5B FCF: Can Cash Momentum Stay Strong?

  • Can Quanta's Electric Business Drive Further Margin Expansion?

  • Can Quanta Convert Record Demand Into Sustainable Shareholder Wins?

  • This Quanta Services Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

  • Sterling vs. Quanta: Which Infrastructure Stock Is the Better Buy?

  • Can Quanta's Acquisition Spree Unlock Another Growth Gear in 2026?

  • Ellen Rubin Joins Quanta Services Board of Directors

  • Can Quanta's $53B Backlog Keep Its Infrastructure Boom Alive?

  • Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

  • Quanta Services Announces Quarterly Cash Dividend